ALK-positive extramedullary plasmacytoma with expression of the CLTC-ALK fusion transcript

Pathology Research and Practice

Volumn 207, Issue 9, 2011, Pages

  Wang, Wei ya ^a   Gu, Ling ^b   Liu, Wei ping ^a   Li, Gan di ^a   Liu, Hua jun ^b   Ma, Zhi gui ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Anaplastic lymphoma kinase (ALK); Extramedullary plasmacytoma; Fusion transcript

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CD20 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; CD79A ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPITHELIAL MEMBRANE ANTIGEN; GENOMIC DNA; PREDNISONE; SYNDECAN 1; VINCRISTINE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLTC ALK GENE; CONTROLLED STUDY; EXTRAMEDULLARY PLASMACYTOMA; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE DISRUPTION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NOSE SURGERY; PLASMACYTOMA; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

DNA, NEOPLASM; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MAGNETIC RESONANCE IMAGING; ONCOGENE PROTEINS, FUSION; PLASMACYTOMA; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 80053969180     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.07.001     Document Type: Article

References (17)

1. Alexiou C., Kau R.J., Dietzfelbinger H., Kremer M., Spiess J.C., Schratzenstaller B., Arnold W. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer 1999, 85:2305-2315.
2. Beltran B., Castillo J., Salas R., Quiñones P., Morales D., Hurtado F., Riva L., Winer E. ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature. J. Hematol. Oncol. 2009, 2:11.
3. Cessna M.H., Zhou H., Sanger W.G., Perkins S.L., Tripp S., Pickering D., Daines C., Coffin C.M. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Modern Pathol. 2002, 15:931-938.
4. Chiarle R., Gong J.Z., Guasparri I., Pesci A., Cai J., Liu J., Simmons W.J., Dhall G., Howes J., Piva R., Inghirami G. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood 2003, 101:1919-1927.
5. Delsol G., Lamant L., Mariamé B., Pulford K., Dastugue N., Brousset P., Rigal-Huguet F., al Saati T., Cerretti D.P., Morris S.W., Mason D.Y. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. Blood 1997, 89:1483-1490.
6. Delsol G., Campo E., Gascoyne R.D. ALK-positive large B-cell lymphoma. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues 2008, 254-255. IARC Press, New York. fourth ed. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stain, J. Thiele, J.W. Vardiman (Eds.).
7. Gascoyne R.D., Lamant L., Martin-Subero J.I., Lestou V.S., Harris N.L., Müller-Hermelink H.K., Seymour J.F., Campbell L.J., Horsman D.E., Auvigne I., Espinos E., Siebert R., Delsol G. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases. Blood 2003, 102:2568-2573.
8. Laurent C., Do C., Gascoyne R.D., Lamant L., Ysebaert L., Laurent G., Delsol G., Brousset P. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis. J. Clin. Oncol. 2009, 27:4211-4216.
9. Lee H.W., Kim K., Kim W., Ko Y.H. ALK-positive diffuse large B-cell lymphoma: report of three cases. Hematol. Oncol. 2008, 26:108-113.
10. Morris S.W., Kirstein M.N., Valentine M.B., Dittmer K.G., Shapiro D.N., Saltman D.L., Look A.T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in Non-Hodgkin's lymphoma. Science 1994, 263:1281-1284.
11. Moshref M., Mashhadi-Abbass F., Sargolzaei S., Nafarzadeh S. Extramedullary plasmacytoma of the gingiva. Arch. Iran Med. 2007, 10:91-93.
12. Onciu M., Behm F.G., Downing J.R., Shurtleff S.A., Raimondi S.C., Ma Z., Morris S.W., Kennedy W., Jones S.C., Sandlund J.T. ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases. Blood 2003, 102:2262-2264.
13. Reichard K.K., McKenna R.W., Kroft S.H. ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature. Modern Pathol. 2007, 20:310-319.
14. Soda M., Choi Y.L., Enomoto M., Takada S., Yamashita Y., Ishikawa S., Fujiwara S., Watanabe H., Kurashina K., Hatanaka H., Bando M., Ohno S., Ishikawa Y., Aburatani H., Niki T., Sohara Y., Sugiyama Y., Mano H. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.
15. Goldstein J.L., Anderson R.G., Brown M.S. Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 1979, 279:679-685.
16. Kutok J.L., Aster J.C. Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma. J. Clin. Oncol. 2002, 20:3691-3702.
17. Bridge J.A., Kanamori M., Ma Z., et al. Fusion of the ALK gene to the clathrin heavy chain gene CLTC, in inflammatory myofibroblastic tumor. Am. J. Pathol. 2001, 159:411-415.